Showing results (41-50 of 59) with videos related to
Sort By:
Pageof 6
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 15, 2024
SEOM-GEM clinical guidelines for cutaneous melanoma (2023)Iván Márquez-Rodas, Eva Muñoz Couselo, Juan F Rodríguez Moreno, et al.Development (Cambridge, England)|October 19, 2019
Epicardial cell shape and maturation are regulated by Wt1 via transcriptional control of <i>Bmp4</i>Víctor Velecela, Alejo Torres-Cano, Ana García-Melero, et al.Transplantation|September 11, 2009
Mammalian target of rapamycin inhibition prevents glomerular hypertrophy in a model of renal mass reductionJordi Rovira, Edgar M Arellano, Joaquim Carreras, et al.Journal of Clinical Medicine|July 9, 2020
PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-AnalysisJorge García-González, Juan Ruiz-Bañobre, Francisco J Afonso-Afonso, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 27, 2025
Retreatment and rechallenge with BRAF/MEK inhibitors in patients with metastatic melanoma: results from the real-world Spanish Melanoma Registry (GEM-1801)Pablo Ayala-de Miguel, Eva Muñoz-Couselo, Lourdes Gutiérrez-Sanz, et al.Nature Communications|December 2, 2021
Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trialMaria Gonzalez-Cao, Clara Mayo de Las Casas, Juana Oramas, et al.Frontiers in Oncology|March 13, 2025
Real-life evidence of encorafenib plus binimetinib in patients with unresectable advanced or metastatic BRAF<sup>V600</sup>-mutant melanoma in Spain: the BECARE (GEM-2002) trialAinara Soria, Pedro Sanchez Mauriño, Juan José Serrano Domingo, et al.Translational Lung Cancer Research|July 28, 2018
Real world data of nivolumab for previously treated non-small cell lung cancer patients: a Galician lung cancer group clinical experienceMª Carmen Areses Manrique, Joaquín Mosquera Martínez, Jorge García González, et al.Plos One|April 16, 2015
Frequency and characteristics of familial melanoma in Spain: the FAM-GEM-1 StudyIván Márquez-Rodas, Manuel Martín González, Eduardo Nagore, et al.Lung Cancer (Amsterdam, Netherlands)|August 28, 2023
Immunogenicity of COVID-19 vaccines in lung cancer patientsMariano Provencio, Anna Estival, Fernando Franco, et al.Pageof 6